Carregant...
Treatment options in non-muscle-invasive bladder cancer after BCG failure
Bladder cancer is the ninth-most prevalent cancer worldwide. Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guérin (BCG) intravesical therapy. Many of these patients experience disease recurrence after BCG f...
Guardat en:
| Publicat a: | Indian J Urol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4626915/ https://ncbi.nlm.nih.gov/pubmed/26604442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.166475 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|